Next Article in Journal
HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
Next Article in Special Issue
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
Previous Article in Journal
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences
Previous Article in Special Issue
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
 
 
Article

Article Versions Notes

Biomedicines 2022, 10(2), 373; https://doi.org/10.3390/biomedicines10020373
Action Date Notes Link
article pdf uploaded. 3 February 2022 12:59 CET Version of Record https://www.mdpi.com/2227-9059/10/2/373/pdf-vor
article xml file uploaded 10 February 2022 07:38 CET Original file -
article xml uploaded. 10 February 2022 07:38 CET Update https://www.mdpi.com/2227-9059/10/2/373/xml
article pdf uploaded. 10 February 2022 07:38 CET Updated version of record https://www.mdpi.com/2227-9059/10/2/373/pdf
article html file updated 10 February 2022 07:40 CET Original file -
article html file updated 31 July 2022 09:58 CEST Update https://www.mdpi.com/2227-9059/10/2/373/html
Back to TopTop